Overview
- Editors:
-
-
Cornelia Kasper
-
Institute of Technical Chemistry, University of Hannover, Hannover, Germany
-
Martijn Griensven
-
Ludwig Boltzmann Institut für, Klinische und Experimentelle, Wien, Austria
-
Ralf Pörtner
-
TU Hamburg-Harburg, Institut für Biotechnologie und Verfahrenstechnik Denickestr. 15, Hamburg, Germany
- Covers trends in modern biotechnology
- All aspects of this interdisciplinary technology, where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemical engineering and computer science, are treated
- More information as well as the electronic version available at springer.com
Access this book
Other ways to access
Table of contents (11 chapters)
-
-
- D. Wendt, S. A. Riboldi, M. Cioffi, I. Martin
Pages 1-27
-
- H. Mertsching, J. Hansmann
Pages 29-37
-
- R. G. Dennis, B. Smith, A. Philp, K. Donnelly, K. Baar
Pages 39-79
-
- A. J. El Haj, K. Hampson, G. Gogniat
Pages 81-93
-
- M. van Griensven, S. Diederichs, S. Roeker, S. Boehm, A. Peterbauer, S. Wolbank et al.
Pages 95-123
-
- S. Concaro, F. Gustavson, P. Gatenholm
Pages 125-143
-
- R. Pörtner, C. Goepfert, K. Wiegandt, R. Janssen, E. Ilinich, H. Paetzold et al.
Pages 145-181
-
-
- J.M. Melero-Martin, S. Santhalingam, M. Al-Rubeai
Pages 209-229
-
- H. Singh, D. W. Hutmacher
Pages 231-249
-
- B. Weyand, M. Israelowitz, H. P. von Schroeder, P. M. Vogt
Pages 251-268
-
Back Matter
Pages 269-271
About this book
The editors of this special volume would first like to thank all authors for their excellent contributions. We would also like to thank Prof. Dr. Thomas Scheper, Dr. Marion Hertel and Ulrike Kreusel for providing the opportunity to compose this volume and Springer for organizational and technical support. Tissue engineering represents one of the major emerging fields in modern b- technology; it combines different subjects ranging from biological and material sciences to engineering and clinical disciplines. The aim of tissue engineering is the development of therapeutic approaches to substitute diseased organs or tissues or improve their function. Therefore, three dimensional biocompatible materials are seeded with cells and cultivated in suitable systems to generate functional tissues. Many different aspects play a role in the formation of 3D tissue structures. In the first place the source of the used cells is of the utmost importance. To prevent tissue rejection or immune response, preferentially autologous cells are now used. In particular, stem cells from different sources are gaining exceptional importance as they can be differentiated into different tissues by using special media and supplements. In the field of biomaterials, numerous scaffold materials already exist but new composites are also being developed based on polymeric, natural or xenogenic sources. Moreover, a very important issue in tissue en- neering is the formation of tissues under well defined, controlled and reprod- ible conditions. Therefore, a substantial number of new bioreactors have been developed.
Editors and Affiliations
-
Institute of Technical Chemistry, University of Hannover, Hannover, Germany
Cornelia Kasper
-
Ludwig Boltzmann Institut für, Klinische und Experimentelle, Wien, Austria
Martijn Griensven
-
TU Hamburg-Harburg, Institut für Biotechnologie und Verfahrenstechnik Denickestr. 15, Hamburg, Germany
Ralf Pörtner